Analysis of Citius Pharmaceuticals Inc. (NASDAQ:CTXR): Selected Notes

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) closed the day trading at $1.14 down -1.72% from the previous closing price of $1.16. In other words, the price has decreased by -$0.0200 from its previous closing price. On the day, 1141712 shares were traded. CTXR stock price reached its highest trading level at $1.2200 during the session, while it also had its lowest trading level at $1.1200.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

For a better understanding of CTXR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.40 and its Current Ratio is at 11.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on November 30, 2021, initiated with a Buy rating and assigned the stock a target price of $4.

Stock Price History:

Over the past 52 weeks, CTXR has reached a high of $2.01, while it has fallen to a 52-week low of $0.83. The 50-Day Moving Average of the stock is 1.1358, while the 200-Day Moving Average is calculated to be 1.1970.

Shares Statistics:

Over the past 3-months, CTXR traded about 483.52K shares per day on average, while over the past 10 days, CTXR traded about 419.68k shares per day. A total of 146.13M shares are outstanding, with a floating share count of 133.82M. Insiders hold about 8.40% of the company’s shares, while institutions hold 11.10% stake in the company. Shares short for CTXR as of Oct 13, 2022 were 11.09M with a Short Ratio of 10.76M, compared to 10.44M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 7.59% and a Short% of Float of 8.29%.

Earnings Estimates

Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$0.04 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.04, while EPS last year was -$0.02. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$0.2 and -$0.2 for the fiscal current year, implying an average EPS of -$0.2. EPS for the following year is $0.41, with 1 analysts recommending between $0.41 and $0.41.